CLINICAL_TRIALS
trial_result
· 2023-05-31
Clinical Trial Update: A Study of Paliperidone Palmitate 6-Month Formulation [Phase 3]
Summary
Phase 3 study evaluating paliperidone palmitate for schizophrenia has completed and posted results for the 6-month formulation.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Janssen Research & Development, LLC | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED | Results posted: 2023-05-31